Achaogen Company
Achaogen, a biopharmaceutical company, discovers and develops broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2004
Employees Number:
1-10
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership